It has been shown that inhibitors blocking the histone-modulating functions of KMT2A, and related genes potently inhibit tumour cell proliferation in glioma cells, a partly by DNA methylation of NOTCH1 and NOTCH3 genomic locus [83]. The gene discussed is NOTCH3; the disease is neoplasm.